Muscle contraction increases skeletal muscle glucose uptake, but the underlying mechanisms are not fully elucidated. While important for insulin-stimulated glucose uptake, the role of Akt in contraction-stimulated muscle glucose uptake is controversial. In our study, C2C12 skeletal muscle myotubes were contracted by electrical pulse stimulation (EPS). We found that EPS leads to Akt phosphorylation on sites S473 and T308 in a time-dependent manner. The Akt inhibitor MK2206 partly reduces EPS-stimulated GLUT4 translocation without affecting EPS-stimulated AMPK phosphorylation. EPS activates Rac1 GTP-binding, and EPS-stimulated GLUT4 translocation is partly inhibited by Rac1 inhibitor II and siRac1. Interestingly, both Rac1 inhibitor II and siRac1 inhibit EPS-stimulated Akt phosphorylation on sites S473 and T308. Our findings implicate a Rac1-Akt signaling pathway in EPS-stimulated GLUT4 translocation in C2C12 myotubes.
Muscle contraction increases skeletal muscle glucose uptake, but the underlying mechanisms are not fully elucidated. While important for insulin-stimulated glucose uptake, the role of Akt in contraction-stimulated muscle glucose uptake is controversial. In our study, C2C12 skeletal muscle myotubes were contracted by electrical pulse stimulation (EPS). We found that EPS leads to Akt phosphorylation on sites S473 and T308 in a time-dependent manner. The Akt inhibitor MK2206 partly reduces EPS-stimulated GLUT4 translocation without affecting EPS-stimulated AMPK phosphorylation. EPS activates Rac1 GTP-binding, and EPS-stimulated GLUT4 translocation is partly inhibited by Rac1 inhibitor II and siRac1. Interestingly, both Rac1 inhibitor II and siRac1 inhibit EPS-stimulated Akt phosphorylation on sites S473 and T308. Our findings implicate a Rac1-Akt signaling pathway in EPS-stimulated GLUT4 translocation in C2C12 myotubes.
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Skeletal muscle is the primary tissue of glucose metabolism, accounting for up to 80% of dietary glucose uptake [1] . Insulin and exercise/muscle contraction are major physiological stimuli that promote skeletal muscle glucose uptake [2, 3] and glucose uptake in skeletal muscle requires redistribution of glucose transporter 4 (GLUT4) proteins to the plasma membrane from intracellular GLUT4 storage vesicles, to transport glucose into muscle fibers [4, 5] . However, GLUT4 translocation is presumably regulated by insulin and contraction through different mechanisms, since the two stimuli can produce additive stimulation of skeletal muscle glucose uptake [5] [6] [7] [8] [9] [10] . The insulin receptor signals through PI-3-kinase to activate two important proximal signaling pathways headed by Akt and Rac1 [11] [12] [13] [14] [15] [16] to regulate GLUT4 translocation. Comparatively, less is known regarding the molecular signal pathways triggered by muscle contraction, but PI-3-kinase has long been reported not to play an important role, instead, AMP-activated protein kinase (AMPK) regulation of Rab-GAP phosphorylation and activity has been heralded, a role that is fulfilled by Akt in response to insulin [17] [18] [19] [20] .
Rac1 is a member of the small Rho family GTPase and plays an important role in various cellular processes, including reorganization of the actin cytoskeleton [21] [22] [23] . Rac1 can be activated by insulin and by stimulating cortical actin remodeling; this pathway is important for the spatial reorganization of GLUT4 vesicles and GLUT4 translocation [13, 15, 24] .
Interestingly, some recent reports have indicated that Rac1 is also necessary for contraction-stimulated glucose uptake in skeletal muscle [25] [26] [27] . Sylow et al. [25, 26] have demonstrated that Rac1 in mouse muscle is involved stretch-and exercise-stimulated glucose uptake, since these stimuli are impaired by inducible muscle-specific Rac1 knockout. But not much is known regarding the upstream or downstream signals engaged by Rac1 for contraction/exercise-stimulated GLUT4 translocation.
Rac1 mediates insulin-stimulated glucose transport in Akt-dependent [14, 28] or Akt-independent [16, 29, 30] manners. In L6 muscle cells, overexpression of constitutively active-Rac leads to Akt phosphorylation [31] . Akt is a key signaling molecule in insulin-regulated muscle glucose transport [32] . However, the role of Akt in contraction-stimulated glucose transport is controversial. Here, we test if electrical stimulation leads to Akt activation. We demonstrate that electrically stimulated contraction in a C2C12 cell line activates Akt in a Rac1-dependent manner, and both signaling molecules contribute to contraction-stimulated GLUT4 translocation.
Materials and methods

Materials
C57/BL6 mice were purchased from Academy of Military Medical Sciences (Beijing, China). C2C12-GLUT4HA cell line was created as described in [33] . Dulbecco's modified Eagle's medium (DMEM), Horse serum (HS), Lipofectamine 2000, and Pierce BCA protein detection kit were from ThermoFisher Scientific (Carlsbad, CA, USA). FBS and trypsin-EDTA were from BioInd (Beit-Haemek, Israel). Humulin R insulin was obtained from Eli Lilly (Indianapolis, IN, USA). Rac1 inhibitorII, Akt inhibitor MK2206, the Rac1/ Cdc42 Activation Assay kit, and Immobilon Western Chemiluminescent HRP Substrate were from EMD Millipore (Bedford, MA, USA). Anti-pan-Akt, anti-Rac, anti-phospho-Akt S473, anti-phospho-Akt T308, antiphospho-PAK T423 and anti-phospho-AMPK T172 antibodies were from Cell Signaling Technology (Danvers, MA, USA). HA epitope tag monoclonal antibody (clone 16B12) was from Biolegend (San Diego, CA, USA). Horseradish peroxidase (HRP)-bound goat antimouse, goat anti-rabbit IgG and donkey anti-mouse IgM antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). Protease inhibitor cocktail, o-phenylenediamine dihydrochloride (OPD), anti-actinin-1 and anti-GAPDH antibodies, and all other chemicals were from Sigma-Aldrich (St. Louis, MO, USA).
Animals
Male C57BL/6 mice were bred in Experimental Animal Center of Tianjin Medical University. Studies were approved by the Tianjin Medical University Animal Care and complied with the guidelines of the Chinese Academy of Sciences. All animals were fed with normal diet (10% calories from fat) for 10 weeks. Mice were acclimatized to the treadmill three times in order to test their maximal running capacity before the experimental day. On experimental day, mice were fasted for 6 h before exercise for 30 min at 75% of their maximal running speed at 0% incline (12 mÁmin À1 ) or intraperitoneal injection with insulin (0.75 IUÁkg À1 body weight, 10 min).
Mice were then sacrificed and skeletal muscles were quickly dissected for the Rac1 activation assay.
Cell culture
C2C12-GLUT4HA myoblasts were maintained in DMEM containing 4.5 gÁL
À1
glucose and 10% FBS (v/v), 5 lgÁmL À1 blasticidin in an atmosphere of 5% CO 2 at 37°C. Myoblasts were seeded onto 6-well plates, grown to confluence and then differentiated into myotubes in DMEM supplemented with 5% horse serum (v/v).
Electrical pulse stimulation (EPS)
C2C12-GLUT4HA myotubes were grown in standard sixwell plates. For experimentation, the cells were cultured in serum-free medium for 2.5 h, pretreated 30 min with inhibitors (as indicated, final concentration of DMSO vehicle was 0.01%, v/v) and then received EPS (20 V, 1 Hz pulses lasting 24 ms at 976-ms intervals) for 60 min using a six-well C-Dish electrode connected to a C-PACE EP Cell Culture Stimulator (Ion Optix, Milton, MA, USA).
Cell surface GLUT4HA quantification
This assay was previously described [34] . Briefly, C2C12-GLUT4HA myotubes were treated as indicated (in triplicate per condition) then washed with ice-cold PBS, fixed with 3% (v/v) paraformaldehyde in PBS for 10 min at 4°C and 20 min at room temperature. The rest of the steps were performed at room temperature and all solutions were made in PBS. Cell plates were next incubated with 0.1 M glycine for 10 min and blocked with 5% nonfat milk (w/v) for 10 min. Cells were reacted with anti-HA monoclonal antibody (1 : 500) in 5% nonfat milk (w/v) for 1 h. After washing with PBS, cells were incubated with HRP-conjugated goat anti-mouse secondary antibody (1 : 1000) in 5% nonfat milk (w/v) for 1 h. The OPD reaction was carried out for up to 20 min in sodium phosphate/citric acid buffer as per manufacturer conditions and then stopped by addition of 3 N HCl. The absorbance of the supernatants was measured at 492 nm (A 492 ). Two wells of C2C12 parental (wild-type) myotubes were included on the plate and served to determine the background primary and secondary antibody binding. The results were calculated by subtraction of the background A 492 from all values and then expressed as the fold changes relative to basal, untreated cells.
Cell lysates and immunoblotting
Protein extracts were made in freshly prepared using 59 Laemmli sample buffer (LSB) supplemented with b-mercaptoethanol at final concentration of 7.5% (v/v). Equal amounts of protein samples were separated by SDS/ PAGE and transferred to polyvinylidene difluoride membranes (Millipore) and immunoblotted with the following primary antibodies to: pan-Akt (1 : 1000), phospho-Akt S473 (1 : 1000), phospho-Akt T308 (1 : 1000), phospho-PAK T423 (1 : 1000), anti-Rac1 (1 : 1000), pan-AMPKa (1 : 1000), phospho-AMPKa T172 (1 : 1000), anti-GAPDH (1 : 1000), and a-actinin 1 (1 : 10 000) as indicated. The protein band densitometries were quantified by using National Institutes of Health (NIH, Bethesda, MD, USA) IMAGE J software.
Small interfering RNA (siRNA) transfection
C2C12-GLUT4HA myotubes were transfected with siRNA oligomers (200 nM) for a nonrelated control or Rac1 using the Lipofectamine 2000 transfection reagent as per the manufacturer's instructions. Cells were transfected first on day 3-4 after seeding, and then a second time, 6-7 days after seeding during differentiation. Experiments were carried out 48 h after the second transfection. The siRNA oligomer target sequences for siRac1 was ACGGU UAAUUUCUGUCAAACATT (gene ID: 7972). Control cells were transfected with a nontargeting sequence of UAAGGCUAUGAAGAGAUACUUTT.
Rac1 activation assay
Rac1 activities were measured by using Rac1/Cdc42 Activation Assay Kit from EMD Millipore. The GST-fusion protein with the p21-binding domain (PBD) of PAK1 was bound to glutathione agarose beads. The PBD specifically bound Rac1 in its GTP-loaded form. The protocol was performed according to the manufacturer's instructions using, per condition: two wells from a six-well plate for lysis in 0.5 mL Mg 2+ Lysis Buffer (MLB). In brief, the lysates were incubated with PAK-1 PBD agarose to bind activated Rac-1(Rac1-GTP) at 4°C for 1 h. The beads were collected by a 5-sec centrifugation at 14 000 g and washed three times with MLB. Next, the beads were resuspended in 29 LSB and boiled for 5 min. The amount of GTPbound Rac1 was detected by immunoblot analysis using the protocol and anti-Rac1 monoclonal antibody provided.
Statistical analysis
Results were expressed as the mean AE SE. Statistical analyses were carried out using PASW Statistics software (Chicago, IL, USA). Two groups were compared using Student's unpaired t-test and more than two groups were compared using analysis of variance (ANOVA) with Tukey' post hoc analysis. P < 0.05 was considered statistically significant.
Results
Electrical pulse stimulation increases Rac1-mediated GLUT4 translocation in cultured muscle cells
Recent studies have demonstrated that skeletal muscle contraction activates Rac1 and implicated its involvement in contraction-stimulated glucose uptake [25, 26] . Rac1 is activated when bound to GTP and consistent with published results, we show in Fig. 1A that both insulin and treadmill running increased Rac1-GTP binding by 2.81 AE 0.22-fold (P < 0.01 vs basal) and 3.08 AE 0.42-fold (P < 0.001 vs basal) in soleus muscles, in which Rac1 is most abundant [25] . To investigate these signaling events further, we utilized a contraction protocol in cultured muscle cells. We previously established an in vitro model to study contraction-regulated signaling and GLUT4 translocation using and electrical pulse stimulation (EPS) with mouse C2C12-GLUT4HA skeletal muscle cells stably expressing a GLUT4 chimeric protein containing an exofacial HA epitope [33] . With these cells we showed, using small molecule inhibitors and siRNA-mediated knockdown, that AMPK and CaMKII were involved in EPS-stimulated GLUT4 translocation [33] . However, when we simultaneously inhibited both kinases, a portion of the EPS-stimulated GLUT4 response remained, suggesting additional pathways were needed for the full response to EPS. Interestingly, Rac1-GTP binding was elevated in C2C12-GLUT4HA myotubes following insulin and EPS treatment (Fig. 1B) and the fold increases were 2.38 AE 0.11-fold and 3.11 AE 0.16-fold (P < 0.01, P < 0.001 vs untreated basal, Fig. 1B) , respectively. In addition, EPS increased phosphorylation of the Rac1 substrate, PAK1 on T423 by 2.41 AE 0.42-fold (P < 0.01 vs untreated basal, Fig. 1C ) and EPS-stimulated phosphorylation of PAK1 was largely due to Rac1 activation, since Rac1 inhibitor II reduced it by 60 AE 0.17% (P < 0.001 vs EPS, Fig. 1D ). Most importantly, Rac1 inhibitor II significantly reduced EPS-stimulated GLUT4 translocation by 72.1 AE 0.04% (1.65 AE 0.02 vs 1.19 AE 0.08-fold, P < 0.01, Fig. 1E ), indicating Rac1 is partly required for the effect of EPS on GLUT4 translocation. To further confirm the effect of Rac1 on EPS-stimulated GLUT4 translocation, we used siRNA-mediated knockdown Rac1 and its expression was reduced by 53% (Fig. 1F) . siRac1 significantly inhibited EPS-stimulated cell surface GLUT4 from 1.50 AE 0.09-fold (P < 0.001, vs basal in siNR group) to 1.06 AE 0.04-fold (P < 0.001, vs EPS in siNR group) (Fig. 1F) . Collectively, these data demonstrated that EPS could trigger Rac activation and signaling and Rac1 activation plays a role in EPS-stimulated GLUT4 translocation.
Electrical pulse stimulation increases Akt-mediated GLUT4 translocation in cultured muscle cells Akt activation has been reported in contracted skeletal muscle by several groups, but its role in skeletal muscle glucose uptake has not been thoroughly investigated. We observed that insulin injection or treadmill running stimulated Akt phosphorylation on S473 and T308 regulatory sites of Akt ( Fig. 2A) . Therefore, we examined if Akt played a role in EPS-stimulated GLUT4 translocation in C2C12-GLUT4HA myotubes. As shown in Fig 2B, phosphorylation of Akt on S473 and T308 was stimulated by EPS in a time-dependent manner with 60 min yielding the greatest effect by an average 3.00 AE 0.58-fold (P < 0.01) and 3.74 AE 0.39-fold (P < 0.001) over untreated cells, respectively. The Akt inhibitor, MK2206, was able to completely eliminate EPS-stimulated Akt phosphorylation (Fig. 2C) . Importantly, MK2206 had no effect on EPS-stimulated AMPK phosphorylation indicating that MK2206 did not have off-target effects toward the AMPK pathway (Fig. 2D) . Finally, Fig. 2E illustrates EPS-stimulated GLUT4 translocation by 1.83 AE 0.07-fold (P < 0.001 vs untreated basal) and this was inhibited by 75.4 AE 0.02% to 1.38 AE 0.03-fold (P < 0.05 vs EPS) without largely affecting basal cell surface levels of GLUT4HA. Collectively, these data suggest Akt is partly involved in the response of EPS-stimulated GLUT4 translocation.
EPS stimulates Akt phosphorylation in a Rac1-dependent manner
Studies have shown that expression of constitutively active Rac1 (CA-Rac1) is sufficient to induce GLUT4 translocation in L6 muscle cells [31] . Interestingly, in these studies, CA-Rac1 triggered a modest increase in Akt phosphorylation. To explore if EPS activated Akt via up-regulation of Rac1 activity in the present study, we analyzed the effect of Rac1 inhibitor II on EPS-induced Akt phosphorylation. We found the EPS-stimulated Akt phosphorylation on sites S473 and T308 [3.96 AE 0.09-fold (P < 0.001, vs basal) and 3.71 AE 0.25-fold (P < 0.001, vs basal)] were decreased by Rac1 inhibitor II to 2.64 AE 0.11-fold (P < 0.001, vs EPS) and 2.48 AE 0.41-fold (P < 0.05, vs EPS), respectively (Fig. 3A) . To further confirm the effect of Rac1 on Akt phosphorylation, we used siRNA to knockdown Rac1 expression by 68.5% (Fig. 3B) . Similar with Rac1 inhibitor II, siRac1 significantly inhibited EPS-induced Akt S473 and T308 phosphorylation from 3.32 AE 0.11-fold (P < 0.001, vs basal in siNR group) and 2.66 AE 0.34-fold (P < 0.01, vs basal in siNR group) to 1.38 AE 0.24-fold (P < 0.001, vs EPS in siNR group) and 1.59 AE 0.28-fold (P < 0.05, vs EPS in siNR group), respectively (Fig. 3C) . Collectively, these data demonstrated that EPS could trigger Akt activation in part through a Rac1-dependent pathway. weight, 10 min), or remained sedentary and untreated (Bas). Soleus muscles were excised and quickly homogenized in Rac1 activation assay lysis buffer and detection of Rac1-GTP by pulldown with GST-PAK1 (PBD) agarose and Rac1 immunoblotting as described in Materials and methods. Immunoblots were quantified using NIH IMAGE J (mean AE SE, n = 6, **P < 0.01, ***P < 0.001 vs Ins or Run vs Bas). (B) C2C12-GLUT4HA myotubes were stimulated with insulin (Ins, 100 nM, 20 min) or EPS (20 V, 1 Hz pulses lasting 24 ms at 976-ms intervals) for 60 min. Cell lysates were analyzed for Rac1-GTP binding as described in (A) and immunoblots were quantified using NIH IMAGE J (mean AE SE, n = 4-5, **P < 0.01 vs insulin or EPS vs basal, ***P < 0.001 EPS vs basal). (C) Cell lysates prepared in B, from EPS-treated C2C12-GLUT4HA myotubes, were also immunoblotted for phospho-PAK1 T423 and PAK1. (D) C2C12-GLUT4HA myotubes were pretreated with DMSO vehicle (0.01% v/v) or Rac1 inhibitor II (20 lM) for 60 min prior to stimulation with EPS and then immunoblotted for phospho-PAK1 T423 and Actinin-1 (mean AE SE, n = 5, ***P < 0.001 vs (À) DMSO or EPS vs EPS + Rac1 inhibitor II). (E) GLUT4HA cell surface levels were measured in cells pretreated with DMSO vehicle or Rac1 inhibitor II followed by EPS (as in B) for 60 min (mean AE SE, n = 5, ***P < 0.001, **P < 0.01 vs (À) DMSO or EPS vs EPS + Rac1 inhibitor II). (F) C2C12-GLUT4HA myotubes were transfected twice with siRNA targeting Rac1 (siRac1, 200 nM) or a nonrelated sequence (siNR, 200 nM) as detailed in Materials and methods. Cell lysates were immunoblotted for Rac1 to assess the level of knockdown, a-Actinin-1 as a loading control. GLUT4HA cell surface levels were also measured (mean AE SE, n = 3, ***P < 0.001 vs siNR (À) EPS or **P < 0.01 EPS + siRac1 vs siNR (+) EPS).
Discussion
Contraction/exercise and insulin are major physiological stimuli of skeletal muscle glucose uptake and it has long been known that these two stimuli can have acute additive effects on muscle glucose uptake [7] [8] [9] [10] . Both insulin and muscle contraction stimulate glucose uptake by promoting GLUT4 translocation to muscle Fasted male C57BL/6 mice were exercised by treadmill running (Run) or injected with insulin (Ins) or left untreated (Bas) and soleus muscle samples were prepared as in Fig. 1A and subjected to immunoblotting of phospho-Akt S473 and phospho-Akt T308 with GAPDH as a loading control. (B) C2C12-GLUT4HA myotubes were stimulated with EPS (as in Fig. 1B) for the times indicated (in minutes) and phospho-Akt S473 and phospho-Akt T308 were immunoblotted and quantified as in the Materials and methods. Actinin-1 served as an immunoblotting loading control. The ratio of phospho-Akt/Akt was calculated for all conditions (mean AE SE, n = 4-5, **P < 0.01, ***P < 0.001 vs basal). (C, D) C2C12-GLUT4HA myotubes were pretreated with DMSO vehicle (0.01% v/v) or Akt inhibitor MK2206 (Akti, 10 lM) for 30 min prior to stimulation with EPS for 60 min. PhosphoAkt S473 and phospho-AMPK T172, panAMPKa and pan-Akt were immunoblotted. Immunoblotted protein band densities were quantified with NIH IMAGE J (mean AE SE, n = 3, ***P < 0.001 vs (À) DMSO or EPS vs EPS + Akti).
(E) GLUT4HA cell surface levels were measured in cells pretreated with DMSO vehicle or Akti for 30 min followed by EPS (as in Fig. 1B ) for 60 min (mean AE SE, n = 3, ***P < 0.01, vs (À) DMSO or EPS vs EPS + Akti, *P < 0.05).
cell surface from intracellular storage vesicles [5, 6, 35] , but because of their additive stimulation of glucose uptake, investigators have been spurred on to understand the differences in the signaling pathways engaged by these stimuli that promote GLUT4 translocation. Insulin-stimulated GLUT4 translocation requires both Akt/AS160 and Rac1/actin signaling cascades in muscle cells [11] [12] [13] [14] [15] [16] . On the other hand, energy demand and calcium fluxes in exercised and contracting muscle activate AMPK and calcium-calmodulin-dependent kinases that are required for contraction-stimulated muscle glucose uptake [36] [37] [38] [39] [40] [41] . Yet, muscle contraction also activates similar signals to insulin: among these, muscle stretch, contraction and exercise activates Rac1 [26, 42] and Akt can be activated by in vitro and in situ muscle contraction and mechanical stretch [43, 44] .
Regarding aerobic exercise, there are some species differences in the acute exercise response of Akt activity. In mice that perform treadmill exercise, we (present study) and others [45] [46] [47] observe stimulation of one or both the S473 or T308 phosphorylation sites of Akt. While in humans, phospho-Akt is either lowered by or not altered by cycling or running exercise relative to pre-exercise activities [48] [49] [50] .
Regarding a role for Akt in exercise-or contractionstimulated glucose uptake in rodent skeletal muscles, the evidence to date is not supportive. Contraction-stimulated Akt activity is not as great in magnitude compared to insulin-stimulated Akt activation in muscle [43] . Furthermore, contraction-stimulated Akt and AS160 phosphorylation, on several sites, (as detected by the PAS antibody) is wortmannin-sensitive [51, 52] , Immunoblotting for phospho-Akt S473 and for phospho-Akt T308 to assess the level of Akt activity with pan-Akt immunoblotting serving as a loading control (mean AE SE, n = 3-4, *P < 0.05, **P < 0.01, ***P < 0.001 vs siNR (À) EPS or EPS vs EPS + siRac1).
but contraction-stimulated glucose uptake is not [53] . In Akt2 knockout mice, contraction cannot stimulate muscle Akt phosphorylation above basal levels [54] , but in these mice stimulation of muscle glucose uptake in response to treadmill exercise or contraction-stimulated GLUT4 translocation are normal [54, 55] . On the other hand, muscle-specific transgenic expression of AMPK-alpha2 inactive or AMPK-alpha2 kinase dead mutants have no contraction-stimulated AMPK activity, but these mice have normal or only partially reduced contraction-stimulated muscle glucose uptake and surprisingly, normal treadmill-stimulated muscle glucose uptake [36, 56, 57] . Nevertheless, the importance of the robust AMPK signaling network in skeletal muscle's contraction-stimulated glucose uptake response has been well-documented [20] . Therefore, there must be multiple inputs, levels of redundancy and a threshold for the stimulation of glucose uptake by contraction. To further explore a role for Akt in contraction-stimulated glucose uptake, it would be interesting to test if contraction-stimulated glucose uptake in AMPK-alpha2 inactive or AMPK-alpha2 kinase dead transgenic mice showed some wortmannin sensitivity, perhaps due to an increased relative importance of Akt signaling (in the absence of AMPK signaling). Indeed, this approach was recently utilized (using the CaMKK inhibitor, STO-609) to reveal a role for CaMKK-alpha in contraction-stimulated glucose uptake [58] .
With our in vitro model of EPS-induced contraction mouse C2C12-GLUT4HA skeletal muscle cells, we previously showed AMPK and CaMKII were activated and required for EPS-stimulated GLUT4 translocation [33] . However, a portion of the EPS-stimulated GLUT4 response remained with simultaneous inhibition of both kinases, suggesting additional pathways were needed for the full response. The present study was aimed to evaluate the role of Rac1 and Akt in the GLUT4 translocation response to C2C12 muscle cell contraction by EPS. Indeed, EPS increased GTPloading of Rac1 and phosphorylation of PAK1 on T423, a downstream effector of Rac1. We confirmed that Rac1 inhibitor II was effective in our system, since EPS-stimulated PAK1 phosphorylation was significantly reduced in cells treated with the inhibitor. Importantly, both Rac1 inhibitor II and siRac1 partially blocked EPS-stimulated GLUT4 translocation by approximately 70% in C2C12-GLUT4HA myotubes. We also observed Akt was phosphorylated on both its regulatory sites (T308 and S473) in a time-dependent by EPS. The Akt inhibitor, MK2206, eliminated EPSstimulated Akt phosphorylation and inhibited GLUT4 translocation by approximately 75% in C2C12-GLUT4HA myotubes, but without affecting AMPK phosphorylation.
It has been previously reported that Akt is activated by low-intensity electrical stimulation in L6 and C2C12 muscle cells [59, 60] and that Rac1-GTP loading is stimulated by EPS in C2C12 muscle cells [27] . Interestingly, we observed in the present study that Rac1 inhibitor II or siRNA-mediated knockdown of Rac1 significantly impaired EPS-stimulated Akt phosphorylation, suggesting Rac1 is upstream of Akt activation by muscle contraction. Initially this was unexpected, but we recalled that expression of CA-Rac1 in L6 muscle cells causes a substantial activation of Akt [31] .
How Rac1 activation leads to Akt activation is unclear, but it may involve the action of Rac1 on the actin cytoskeleton, since disruption of the actin cytoskeleton with cytochalasin D lowers insulin-stimulated Akt activation in L6 muscle cells [61] . Insulin-stimulated Rac1 is required for actin remodeling [23, 62] and we hypothesize that contraction-stimulated Rac1 (by mechanical stretch) may subsequently lead to cortical b-actin reorganization and Akt activation. Alternatively, other means by which contraction activates Akt has been shown using electrical stimulation to induce release of extracellular ATP from primary rat myotubes, which leads to autocrine/paracrine activation of purinergic receptors via an Akt intracellular signaling pathway to increase GLUT4 translocation [17] . However, if this pathway involves Rac1 is yet to be determined. Future experiments by our laboratories will address these possibilities.
In summary, we used mouse C2C12-GLUT4HA myotubes and an EPS in vitro contraction model to investigate the role of Rac1 and Akt activation in contraction-stimulated GLUT4 translocation. We show that EPS stimulates Rac1 GTP-loading and Rac1-dependent phosphorylation of PAK1. We further demonstrate that that EPS stimulates Rac1-dependent activation of Akt and that Akt inhibition partly reduces EPS-stimulated GLUT4 translocation. Further studies will focus on mechanism by which Rac1 regulates Akt activity and EPS-stimulated GLUT4 translocation. Ultimately, lessons learned from this valuable cell culture system could be tested in mature skeletal muscle to identify signaling pathways emanating from contraction-stimulated Rac1 and explore possible avenues to bypass or overcome insulin resistance. 
